<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Discharge Instructions</a></li><li><a href="#id6">Medications at Time of Discharge</a></li><li><a href="#id7">H&amp;P Notes</a></li><li><a href="#id8">OR Notes</a></li><li><a href="#id9">Plan of Treatment</a></li><li><a href="#id10">Procedures</a></li><li><a href="#id11">Results</a></li><li><a href="#id12">Visit Diagnoses</a></li><li><a href="#id13">Admitting Diagnoses</a></li><li><a href="#id14">Administered Medications</a></li><li><a href="#id15">Active and Recently Administered Medications</a></li><li><a href="#id16">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li>Auth/Cert: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td/><td><p>Diagnoses</p><p>Prostate cancer (HCC)</p><p>Prostate cancer</p><br/><p>Procedures</p><p>PR TRANSPERINEAL PLMT BIODEGRADABLE MATRL 1/MLT NJX</p><p>TRANSPERINEAL HYDRO GEL SPACE OAR INJECTION</p></td><td><p/></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>11102920</td><td class="xflagData"/><td/><td/><td/><td>1</td><td>1</td></tr></tbody></table><br/></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter2" class="xRowNormal"><td>[REDACTED]  7:30 AM CDT - [REDACTED]  8:20 AM CDT</td><td ID="encounter2type">Surgery</td><td><p>[REDACTED] OR Surgery</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]-2122</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>Suite 1000</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><span class="content_span">TRANSPERINEAL HYDRO GEL SPACE OAR INJECTION</span></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist6"><colgroup><col span="2" width="25%"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist6packsperday"/><td/><td/></tr><tr ID="sochist6smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Yes</td><td>2 (1 standard drink = 0.6 oz pure alcohol)</td><td>weekend</td></tr></tbody></table><table><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex9"><td>Sex Assigned at Birth</td><td ID="BirthSex9Value">Not on file</td><td/></tr><tr ID="GenderIdentity7"><td>Gender Identity</td><td ID="GenderIdentity7Value">Not on file</td><td/></tr><tr ID="SexualOrientation8"><td>Sexual Orientation</td><td ID="SexualOrientation8Value">Not on file</td><td/></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Job Start Date</th><th>Occupation</th><th>Industry</th></tr></thead><tbody><tr><td>Not on file</td><td ID="sochist10">Not on file</td><td ID="sochist11">Not on file</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">112</span>/<span class="content_span">57</span></td><td>[REDACTED]  8:09 AM CDT</td><td/></tr><tr ID="pulse_5732773740" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>70</td><td>[REDACTED]  8:09 AM CDT</td><td/></tr><tr ID="temp_5732773740" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.5 °C (97.7 °F)</td><td>[REDACTED]  8:09 AM CDT</td><td/></tr><tr ID="resp_5732773740" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>18</td><td>[REDACTED]  8:09 AM CDT</td><td/></tr><tr ID="SpO2_5732773740" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>97%</td><td>[REDACTED]  8:09 AM CDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5732764440" class="xRowNormal"><td class="xcellHeader">Weight</td><td>96.2 kg (212 lb)</td><td>[REDACTED]  5:34 AM CDT</td><td/></tr><tr ID="height_5732764440" class="xRowAlt"><td class="xcellHeader">Height</td><td>165.1 cm (5' 5")</td><td>[REDACTED]  5:34 AM CDT</td><td/></tr><tr ID="bmi_5732764440" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>35.28</td><td>[REDACTED]  5:34 AM CDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Discharge Instructions</a></h3><div><ul><li>Discharge Instr - Other Orders: <ul><li><p> <span class="xLabel">[REDACTED], RN - [REDACTED]  8:20 AM CDT</span></p><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/>GENERAL POST-OPERATIVE AND POST PROCEDURE <br/>PATIENT INSTRUCTIONS<br/><br/>FOLLOW-UP: <br/>Please make an appointment with your physician in {NUMBER:18281} {TIME PERIOD:9076}. <br/><br/>Call your physician immediately if you have:<br/><br/>Persistent nausea or vomiting.  <br/>Fever greater than 100.5 degrees Fahrenheit.<br/>increasing abdominal pain<br/>problems urinating<br/>Observed possible signs of infection at your IV site: <br/>Redness<br/>Swelling<br/>Heat <br/>Red streaks<br/><br/>OR <br/><br/>Any of the following at your Operative site:<br/>Increased pain that is unrelieved by pain medication and comfort measures<br/>Increased swelling, numbness or tingling<br/>Change in color<br/>Excessive or persistent bleeding<br/>Foul odor or drainage<br/>Coldness<br/><br/>ACTIVITY:<br/>You are encouraged to walk and engage in light activity for the next two weeks (unless otherwise instructed by your surgeon).<br/>You are encouraged to cough and take deep breaths, or if you were given one, use your incentive spirometer every 15-30 minutes when awake. This will help prevent respiratory complications and low grade fevers post-operatively if you had a general anesthetic. <br/>If you had abdominal or chest surgery, you may want to hug a pillow when coughing and sneezing to add additional support to the surgical area. <br/>Leg exercises or movement is recommended every two hours while awake to improve circulation (unless otherwise instructed by your physician). <br/>No smoking for at least 6 hours post operatively or until fully awake. <br/>Smoking is discouraged as it decreases circulation and slows the healing process. Please speak with you surgeon or family doctor about methods to stop smoking. <br/><br/> <br/>ANESTHESIA<br/>Anesthesia and/or other medications will be in your body for 24 hours so you may feel slightly drowsy. This feeling will slowly wear off, but you should not drive a car, operate power tools, or heavy machinery or make important decisions. <br/>You may experience a sore throat.  Warm salt water gargles or throat lozenges may be helpful.<br/>Slight muscle ache is normal after surgery and will wear off. <br/>No alcoholic beverages for 24 hours after anesthesia.<br/><br/>DIET: <br/>You may eat any foods that you can tolerate. Avoid spicy and fried foods for the first day to prevent nausea.  <br/>You can prevent constipation by walking, eating high fiber foods, and drinking plenty of fluids. High fiber foods include beans, vegetables, prunes and whole grain breads and cereals.   <br/>If you do become constipated, you may be able to take a mild laxative on a daily basis until your bowel habits are regular. Please check with your surgeon or family physician before starting any new medication. <br/><br/>FRACTURE AND CAST CARE:<br/>Elevate the injured part to lessen swelling.<br/>Casts [REDACTED] in 48 hours and must be kept dry at all times. <br/>No weight or pressure on your cast unless instructed otherwise by your physician. <br/>Wiggle your toes or fingers to help prevent swelling in the cast, unless otherwise instructed by your physician. <br/>Notify your physician if there is excessive pain, numbness or blue color in your fingers or toes.<br/><br/>MEDICATIONS: <br/>If prescribed to you, try to take narcotic medications and anti-inflammatory medications, such as Tylenol, ibuprofen, Naprosyn, etc., with food. This will minimize stomach upset from the medication. <br/>Check with your surgeon before taking any aspirin products.<br/>Should you develop nausea and vomiting from the pain medication, or develop a rash, please discontinue the medication and contact your physician. <br/>If you experienced nausea in the recovery phase after surgery, you may have received a Quese Ease Aromatherapy quick tab. Quese Ease contains essential oils known to reduce nausea and is good to use for 72 hours. <br/>To use: hold the quick tab under your nose and  take slow deep breaths in through your nose for approximately 5 minutes.<br/>You should not drive, make important decisions, or operate machinery when taking narcotic pain medication.<br/>If you were prescribed antibiotics, take them as prescribed and until all gone. <br/>Do not drink alcohol while taking pain medications.<br/><br/>WOUND CARE INSTRUCTIONS: <br/>Do not remove your dressing until instructed to do so by your surgeon. If you have any questions about when to remove your dressing please call the surgeon's office.<br/>Once your surgeon has removed the dressing or instructed you to do so: <br/>Keep a dry, clean dressing on the wound if there is drainage.<br/>Once the wound has quit draining, you may leave it open to air.<br/>If clothing rubs against the wound or causes irritation and the wound is not draining, you may cover it with a dry dressing during the daytime. <br/>Try to keep the wound dry and avoid ointments on the wound unless directed to do so.<br/> If the wound becomes bright red and painful or starts to drain liquid that is not clear or has bad odor please contact your physician immediately.<br/> If the wound is mildly pink and has a thick firm ridge underneath it, this is normal and is referred to as a healing ridge. This will resolve over the next 4-6 weeks.<br/>      <br/><br/>QUESTIONS: Please feel free to call your physician if you have any questions, and they will be glad to assist you. If you feel you are having an emergency and are unable to reach your physician proceed to the emergency room. <br/><br/>I ACKNOWLEDGE RECEIPT OF THE ABOVE INSTRUCTIONS AND UNDERSTAND THEM.<br/><br/>Patient or Responsible Party Signature: _____________________________<br/>Date: [REDACTED]<br/>How to Quit Smoking<br/><br/>Smoking is one of the hardest habits to break. About half of all people who have ever smoked have been able to quit. Most people who still smoke want to quit. Here are some of the best ways to stop smoking.<br/><br/>Keep trying<br/>It takes most smokers about eight tries before they can quit entirely. It’s important not to give up.<br/><br/>Go cold turkey<br/>Most former smokers quit cold turkey (all at once). Trying to cut back gradually doesn't seem to work as well, perhaps because it continues the smoking habit. Also, it is possible to inhale more while smoking fewer cigarettes. This results in the same amount of nicotine in your body!<br/><br/>Get support<br/>Support programs can be a big help, especially for heavy smokers. These groups offer lectures, ways to change behavior, and peer support. Here are some ways to find a support program:<br/><br/>[REDACTED] TOBACCO QUIT HOTLINE (877-937-7848).<br/>Free national quitline: 800-QUIT-NOW (800-784-8669).<br/>Hospital quit-smoking programs.<br/>American Lung Association: (800-586-4872).<br/>American Cancer Society (800-227-2345).<br/>Support at home is important too. Nonsmokers can offer praise and encouragement. If the smoker in your life finds it hard to quit, encourage them to keep trying!<br/><br/>Over-the-counter medicines<br/>Nicotine replacement therapy may make quitting easier. Certain aids, such as the nicotine patch, gum, and lozenges, are available without a prescription. It is best to use these under a doctor’s care, though. The skin patch provides a steady supply of nicotine. Nicotine gum and lozenges give temporary bursts of low levels of nicotine. Both methods reduce the craving for cigarettes. <br/><br/>Warning: If you have nausea, vomiting, dizziness, weakness, or a fast heartbeat, stop using these products and see your doctor.<br/><br/>Prescription medicines<br/>After reviewing your smoking patterns and prior attempts to quit, your doctor may offer a prescription medicine such as bupropion, varenicline, a nicotine inhaler, or nasal spray. Each has advantages and side effects. Your doctor can review these with you.<br/><br/>Health benefits of quitting<br/>The benefits of quitting start right away and keep improving the longer you go without smoking. These benefits occur at any age.  So whether you are [REDACTED] or [REDACTED], quitting is a good decision. Some of the benefits include:<br/>20 minutes: Blood pressure and pulse return to normal.<br/>8 hours: Oxygen levels return to normal.<br/>2 days: Ability to smell and taste begin to improve as damaged nerves regrow.<br/>2 to 3 weeks: Circulation and lung function improve.<br/>1 to 9 months: Coughing, congestion, and shortness of breath decrease; tiredness decreases.<br/>1 year: Risk of heart attack decreases by half.<br/>5 years: Risk of lung cancer decreases by half; risk of stroke becomes the same as a nonsmoker’s.<br/>For more on how to quit smoking, try these online resources: <br/>Smokefree.gov<br/>"Clearing the Air" booklet from the National Cancer Institute: smokefree.gov/sites/default/files/pdf/clearing-the-air-accessible.pdf<br/><br/>Symptoms of a Stroke<br/><br/>During a stroke, blood stops flowing to part of the brain. This can damage areas in the brain that control the rest of the body. Get help right away if any of these symptoms come on suddenly, even if the symptoms don’t last.<br/><br/>Know the symptoms of a stroke<br/>Weakness. You may feel a sudden weakness, tingling, or a loss of feeling on 1 side of your face or body including your arm or leg. <br/>Vision problems. You may have sudden double vision or trouble seeing in 1 or both eyes.<br/>Speech problems. You may have sudden trouble talking, slurred speech, or problems understanding others.<br/>Headache. You may have a sudden, severe headache.<br/>Movement problems. You may have sudden trouble walking, dizziness, a feeling of spinning, a loss of balance, a feeling of falling, or blackouts.<br/>Seizure. You may also have a seizure with a large or hemorrhagic stroke. <br/><br/>Remember: If you have any of these symptoms, call 911 and your doctor as soon as possible.<br/>F.A.S.T. is an easy way to remember the signs of a stroke. When you see these signs, you will know that you need to call 911 fast. <br/>F.A.S.T. stands for:<br/>F is for face drooping - One side of the face is drooping or numb. When the person smiles, the smile is uneven.<br/>A is for arm weakness - One arm is weak or numb. When the person lifts both arms at the same time, one arm may drift downward.<br/>S is for speech difficulty - You may notice slurred speech or difficulty speaking. The person can't repeat a simple sentence correctly when asked.<br/>T is for time to dial 911 - If someone shows any of these symptoms, even if they go away, call 911 immediately. Make note of the time the symptoms first appeared. <br/> </content><br/><span class="xLabel">Electronically signed by [REDACTED], RN at [REDACTED]  8:20 AM CDT</span><br/><br/></li></ul></li><li>Attachments: <p>The following attachments cannot be sent through Care Everywhere.</p><ul><li>Cephalexin tablets or capsules (Spanish)</li><li>Acetaminophen; Hydrocodone tablets or capsules (Spanish)</li></ul></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Medications at Time of Discharge</a></h3><div><table><colgroup><col span="2" width="25%"/><col width="13%"/><col span="2" width="12%"/><col width="13%"/></colgroup><thead><tr><th>Medication</th><th>Sig</th><th>Dispensed</th><th>Refills</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr ID="dcrx30" class="xRowNormal"><td><p>rosuvastatin (CRESTOR) 20 mg tablet</p></td><td ID="sig30">TAKE 1 TABLET BY MOUTH 1 TIME AT NIGHT</td><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx31" class="xRowAlt"><td><p>UNABLE TO FIND</p></td><td ID="sig31">Med Name: "Dragon" topical cream (over the counter) as needed for pain</td><td/><td/><td/><td/></tr><tr ID="dcrx32" class="xRowNormal"><td><p>glimepiride (AMARYL) 4 MG tablet</p></td><td ID="sig32">Take 1 tablet (4 mg total) by mouth daily. with food -</td><td/><td/><td>[REDACTED]</td><td/></tr><tr ID="dcrx33" class="xRowAlt"><td><p>tamsulosin (FLOMAX) 0.4 mg capsule</p><content class="xallIndent">Indications: <span class="content_span">Prostate cancer (HCC)</span></content></td><td ID="sig33">TK 1 C PO Q NIGHT</td><td><p>90 capsule</p></td><td>2</td><td>[REDACTED]</td><td/></tr><tr ID="dcrx36" class="xRowNormal"><td><p>lisinopriL (PRINIVIL) 10 mg tablet</p></td><td ID="sig36">Take 1 tablet (10 mg total) by mouth daily.</td><td/><td>0</td><td>[REDACTED]</td><td/></tr><tr ID="dcrx23" class="xRowAlt"><td><p>cephalexin (Keflex) 500 MG capsule</p></td><td ID="sig23">Take 1 capsule (500 mg total) by mouth 3 (three) times a day for 1 day.</td><td><p>3 capsule</p></td><td/><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx24" class="xRowNormal"><td><p>HYDROcodone-acetaminophen (Norco) 5-325 mg per tablet</p><content class="xallIndent">Indications: <span class="content_span">acute pain</span></content></td><td ID="sig24">Take 1 tablet by mouth every 6 (six) hours as needed for moderate pain for up to 10 days .acute pain. Max Daily Amount: 4 tablets</td><td><p>8 tablet</p></td><td/><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx26" class="xRowAlt"><td><p>abiraterone (ZYTIGA) 250 mg chemo tablet</p><content class="xallIndent">Indications: <span class="content_span">Prostate cancer (HCC)</span>, <span class="content_span">H/O ongoing treatment with hormonal therapy</span></content></td><td ID="sig26">Take 4 tablets (1,000 mg total) by mouth daily for 90 days.</td><td><p>120 tablet</p></td><td>2</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx29" class="xRowNormal"><td><p>predniSONE (DELTASONE) 5 mg tablet</p></td><td ID="sig29">Take 1 tablet (5 mg total) by mouth daily.</td><td><p>90 tablet</p></td><td>3</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx35" class="xRowAlt"><td><p>metFORMIN (GLUCOPHAGE) 500 mg tablet</p></td><td ID="sig35">Take 1 tablet (500 mg total) by mouth daily. 2 TABS QHS</td><td/><td/><td/><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id7" href="#toc">H&amp;P Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED]  6:54 AM CDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Urology H&amp;P<br/><br/>Chief Complaint: SpaceOAR consultation<br/><br/>History Of Present Illness:<br/>[REDACTED] is a pleasant [REDACTED].-old  male with history of metastatic castrate resistant prostate cancer [REDACTED] score (4+5) 9.  He is currently receiving abi+prednisone with androgen deprivation therapy with [REDACTED]. <br/>He has been doing well and taking his supplements.<br/>No issues with urination. <br/><br/>In the interim patient had colonoscopy with a tumor found in the cecum that was biopsied and found to be tubulovillous adenoma.  Patient is undergoing a another colonoscopy with resection [REDACTED].<br/> Latest Reference Range &amp; Units [REDACTED] 13:39 [REDACTED] 16:02 [REDACTED] 10:18 [REDACTED] 08:17 [REDACTED] 11:25 [REDACTED] 09:25 [REDACTED] 11:52 <br/>PSA &lt; OR = 4.00 ng/mL 1.7 [1] 2.8 [2] 3.8 [3] 0.74 [4] 0.30 [5] 0.25 [6] 0.16 [7] <br/><br/>Here for spaceoar placement<br/><br/>He denies any interim illnesses or hospitalizations.<br/>He denies interim urinary tract infections.<br/>He denies interim hematuria, pelvic, rectal or abdominal pain.<br/><br/>Past Medical History: <br/>Diagnosis Date <br/> Diabetes mellitus (HCC)  <br/> Hyperlipidemia  <br/> Hypertension  <br/> Prostate cancer (HCC)  <br/> Type 2 diabetes mellitus (HCC)  <br/><br/>Past Surgical History: <br/>Procedure Laterality Date <br/> BIOPSY, PROSTATE, USING NEEDLE N/A [REDACTED] <br/> Procedure: Cystoscopy Transrectal Ultrasound Guided Prostate Biopsy;  Surgeon: [REDACTED][REDACTED], [REDACTED];  Location: HMSJ OR;  Service: Urology;  Laterality: N/A; <br/> COLONOSCOPY N/A [REDACTED] <br/> Procedure: COLONOSCOPY with BX;  Surgeon: [REDACTED], [REDACTED];  Location: HMSJ ENDOSCOPY;  Service: Gastroenterology;  Laterality: N/A;  Large cecal polyp  <br/> COLONOSCOPY N/A [REDACTED] <br/> Procedure: COLONOSCOPY W/ EMR , polypectomies and clip x5;  Surgeon: Dacha, Sunil, MD;  Location: HMH ENDOSCOPY;  Service: Gastroenterology;  Laterality: N/A; <br/> HERNIA REPAIR  1991 <br/><br/>Current Facility-Administered Medications: <br/>  ceFAZolin 2 g in sodium chloride 0.9 % MBP 50 mL IVPB, 2 g, intravenous, Once, [REDACTED], MD<br/>  fentaNYL (SUBLIMAZE) injection 25 mcg, 25 mcg, intravenous, Q5 [REDACTED], [REDACTED], MD<br/>  naloxone (NARCAN) 0.4 mg/mL injection 0.1 mg, 0.1 mg, intravenous, Q1 Min PRN, [REDACTED], MD<br/>  ondansetron ODT (ZOFRAN-ODT) disintegrating tablet 4 mg, 4 mg, oral, Once PRN **OR** ondansetron (ZOFRAN) injection 4 mg, 4 mg, intravenous, Once PRN, [REDACTED], MD<br/><br/>Facility-Administered Medications Ordered in Other Encounters: <br/>  acetaminophen (TYLENOL) tablet 650 mg, 650 mg, oral, Q4H PRN, de Las [REDACTED], MD<br/>  diphenhydrAMINE (BENADRYL) injection 25 mg, 25 mg, intravenous, Once PRN, de Las [REDACTED], MD<br/>  EPINEPHrine (ADRENALIN) 1 mg/mL injection FOR IM/SQ USE 0.5 mg, 0.5 mL, subcutaneous, Once PRN, de Las [REDACTED], MD<br/>  denosumab (XGEVA) injection 120 mg, 120 mg, subcutaneous, Once, de Las [REDACTED], MD<br/><br/>No Known Allergies<br/><br/>No family history on file.<br/><br/>Social History <br/><br/>Socioeconomic History <br/> Marital status: Married <br/>  Spouse name: None <br/> Number of children: None <br/> Years of education: None <br/> Highest education level: None <br/>Occupational History <br/> None <br/>Tobacco Use <br/> Smoking status: Never <br/> Smokeless tobacco: Never <br/>Vaping Use <br/> Vaping Use: Never used <br/>Substance and Sexual Activity <br/> Alcohol use: Yes <br/>  Alcohol/week: 2.0 - 3.0 standard drinks <br/>  Types: 2 - 3 Cans of beer per week <br/>  Comment: weekend <br/> Drug use: Never <br/> Sexual activity: Defer <br/>Other Topics Concern <br/> None <br/>Social History Narrative <br/> None <br/><br/>Social Determinants of Health <br/><br/>Financial Resource Strain: Not on file <br/>Food Insecurity: Not on file <br/>Transportation Needs: Not on file <br/>Physical Activity: Not on file <br/>Stress: Not on file <br/>Social Connections: Not on file <br/>Intimate Partner Violence: Not on file <br/>Housing Stability: Not on file <br/><br/>Review of Systems:  <br/>Full 10 point review of systems obtained and negative except for pertinent positives mentioned in HPI.<br/><br/>Objective<br/><br/>Physical Exam: <br/>Wt Readings from Last 3 Encounters: <br/>[REDACTED] 96.2 kg (212 lb) <br/>[REDACTED] 95.8 kg (211 lb 3.2 oz) <br/>[REDACTED] 91.6 kg (202 lb) <br/><br/>Temp Readings from Last 3 Encounters: <br/>[REDACTED] 96.8 °F (Temporal) <br/>[REDACTED] 97.9 °F (Temporal) <br/>[REDACTED] 98.5 °F (Oral) <br/><br/>BP Readings from Last 3 Encounters: <br/>[REDACTED] 156/70 <br/>[REDACTED] 144/65 <br/>[REDACTED] 154/67 <br/><br/>Pulse Readings from Last 3 Encounters: <br/>[REDACTED] 74 <br/>[REDACTED] 71 <br/>[REDACTED] 80 <br/><br/>General: Alert, Awake, Oriented X3, no acute distress<br/>Heart: regular rate and rhythm<br/>Lungs: unlabored respirations<br/>Abdomen: soft, non-distended, non-tender to palpation, no flank tenderness<br/>Extremities: no cyanosis or edema <br/><br/>Laboratory Studies:<br/>CBC, Coags, BMP, Mg, Phos @MDALABRCNT(wbc,hgb,hct,plt,inr,ptt,sodiumlvl,potassiuml,chloride,carbdiox,bun,creatinine,gluclv,ionzdcalc,calcium,maglvl,phospho)@<br/>Liver Function, Amylase &amp; Lipase @MDALABRCNT(ttlprotein,alblvl,alt,ast,alkphos,bilitot,lacticacid)@<br/>Urinalysis @MDALABRCNT(urspgrav,uph,uaprot,uagluc,uaketones,uablood,uawbc,uarbc,uanitrite,uabili,uaurobil,uabacteria,uauric)@<br/><br/>IMAGING:<br/>No results found.<br/><br/>Assessment/Plan <br/><br/>[REDACTED].-old  male with <br/><br/>1. There are no diagnoses linked to this encounter.<br/> <br/><br/>PLAN:<br/>To the OR for transperineal spaceoar placement.<br/>Note: Speech to text translation software is utilized for the following note.  Please excuse translation/transcription errors.<br/><br/>[REDACTED], [REDACTED]<br/>Houston Methodist Urology Associates<br/>[REDACTED][REDACTED] <br/>[REDACTED]<br/>[REDACTED]<br/>OFFICE: [REDACTED]<br/>FAX: [REDACTED]<br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  6:55 AM CDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id8" href="#toc">OR Notes</a></h3><div><ul><li>Op Note - [REDACTED], MD - [REDACTED]  7:49 AM CDT: <content><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Urology Operative Note<br/><br/>[REDACTED]<br/>051351195<br/>[REDACTED].<br/>male<br/>[REDACTED]<br/>HMB OR 01<br/><br/>Pre-op Diagnosis:  <br/>Prostate cancer<br/>   <br/>Post-Op Diagnosis Codes:<br/>   * Prostate cancer (HCC) [C61]<br/><br/>Procedure(s):<br/>TRANSPERINEAL HYDRO GEL SPACE OAR INJECTION<br/><br/>Surgeon(s) and Role:<br/>   * [REDACTED], MD - Primary<br/><br/>Indication: [REDACTED] gentleman who was found to have prostate cancer.  He opted to proceed with radiation for treatment.  Decision was made that he would benefit from space oar hydrogel injection to decrease risk of radiation damage to his rectum.  Procedure, risk and benefits were discussed with him in detail and he consented to proceed.<br/><br/>Anesthesia: General w/ TIVA<br/><br/>Estimated Blood Loss: 1 mL<br/><br/>Total IV Fluids: see Anesthesia record<br/><br/>Blood Products Administered: None<br/>       <br/>Drains: No LDAs Documented <br/>       <br/>Specimens: * No specimens in log *<br/><br/>Grafts/Implants: None<br/><br/>Complications: None<br/>       <br/>Disposition: PACU - hemodynamically stable.<br/>       <br/>Condition: stable<br/><br/>Findings: Good separation of the prostate from rectum with good placement of SpaceOAR hydrogel with no violation into the rectum<br/><br/>Procedure Details<br/><br/>After informed consent was obtained, patient was brought back into the operating room.  He was placed under anesthesia.  He was transferred to the dorsolithotomy position.  His perineum was prepped and draped in standard sterile fashion.  Timeout was performed.  Ultrasound probe was placed into the rectum.  Prostate was well visualized on the ultrasound.  Lidocaine was injected subcutaneously up towards the apex of the prostate under ultrasound guidance.  Next our space oar needle was placed into the space between the prostate and the rectum (denoviellier's fascia) and advanced under ultrasound guidance towards the mid gland of the prostate.  Saline was injected for hydro-dissection.  The space oar hydrogel kit was assembled.  It was connected to the needle.  The gel was then slowly injected.  We had a nice separation of the rectum from the prostate.  We confirmed good placement of the gel on sagittal and coronal images under ultrasound.  We were satisfied with the placement of the gel.  The needle was removed.  Ultrasound probe was removed from the rectum.  Patient was transferred back to supine position.  Anesthesia was reversed.  Patient was transferred to the recovery room in stable condition without any complications.<br/><br/>Disposition: The patient will be discharged home [REDACTED].  He will follow-up with urology [REDACTED] with a PSA prior.  Patient will initiate radiation therapy soon.<br/>  <br/><br/>[REDACTED], MD <br/><br/>Date: [REDACTED]  Time: 8:07 AM<br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  8:09 AM CDT</span><br/></content></li><li>Perioperative Nursing Note - [REDACTED], RN - [REDACTED]  7:39 AM CDT: <content><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Patient ambulated to the restroom and voided. </content><br/><span class="xLabel">Electronically signed by [REDACTED], RN at [REDACTED]  8:45 AM CDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id9" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter53" class="xRowNormal"><td>[REDACTED] 10:00 AM CST</td><td ID="encounter53type">Office Visit</td><td><p>Houston Methodist Oncology Partners</p><p>[REDACTED][REDACTED]</p><p>Suite 101</p><p>[REDACTED]-3154</p><p>[REDACTED]</p></td><td><p>Naik, [REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>Suite 101</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter52" class="xRowAlt"><td>[REDACTED]  9:45 AM CST</td><td ID="encounter52type">Lab</td><td><p>[REDACTED] Outpatient Lab</p><p>[REDACTED][REDACTED]</p><p>Suite 103</p><p>[REDACTED]-3161</p><p>[REDACTED]</p></td><td><p>Naik, [REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>Suite 101</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter51" class="xRowNormal"><td>[REDACTED]  9:45 AM CST</td><td ID="encounter51type">Nurse Only</td><td><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>Suite 101</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter50" class="xRowAlt"><td>[REDACTED]  9:30 AM CDT</td><td ID="encounter50type">Office Visit</td><td><p>Houston Methodist Urology Associates</p><p>[REDACTED][REDACTED]</p><p>Suite 307</p><p>[REDACTED]-3156</p><p>[REDACTED]</p></td><td><p>[REDACTED][REDACTED], NP</p><p>[REDACTED][REDACTED]</p><p>Suite 307</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id10" href="#toc">Procedures</a></h3><div><table><colgroup><col width="25%"/><col width="10%"/><col width="15%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Procedure Name</th><th>Priority</th><th>Date/Time</th><th>Associated Diagnosis</th><th>Comments</th></tr></thead><tbody><tr ID="procedure59" class="xRowNormal"><td><span class="content_span">TRANSPERINEAL HYDRO GEL SPACE OAR INJECTION</span></td><td/><td>[REDACTED]  7:30 AM CDT</td><td><p>Prostate cancer (HCC)</p></td><td/></tr><tr class="xRowNormal"><td/><td colspan="4"><p>Special Needs</p><p>rep must be available.[REDACTED]- fortec confirmation #773217602</p></td></tr><tr ID="procedure58" class="xRowAlt"><td><span class="content_span">POC GLUCOSE</span></td><td>Routine</td><td>[REDACTED]  6:01 AM CDT</td><td/><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.430.2.7.2.798268.575519085">results section</span>.</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id11" href="#toc">Results</a></h3><div><ul><li>(ABNORMAL) POC glucose ([REDACTED]  6:01 AM CDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col span="2" width="10%"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.430.2.7.2.798268.575519085.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.430.2.7.2.798268.575519085.Comp1Name">POC glucose</td><td><span class="xflagData">117</span><span class="xflagData"> (H)</span></td><td>65 - 100 mg/dL</td><td/><td>[REDACTED]  6:02 AM CDT</td><td>[REDACTED]</td><td ID="Result.1.2.840.114350.1.13.430.2.7.2.798268.575519085.Comp1Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">Operator Name: [REDACTED]<br/>Device ID: UU14407858<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.430.2.7.2.798268.575519085.Specimen"/><td/><td/><td>[REDACTED]  6:01 AM CDT</td><td>[REDACTED]  6:02 AM CDT</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>POINT OF CARE TEST ORDERABLES</td></tr></tbody></table><table><colgroup><col span="3" width="20%"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.430.2.7.2.798268.575519085.PerformingLab"><p>HMH DEPARTMENT OF PATHOLOGY AND GENOMIC MEDICINE</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED]</p></td><td><p/></td></tr><tr><td><p>[REDACTED]</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED], [REDACTED] 77521</p></td><td><p/></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id12" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx40" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (HCC)</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr><tr ID="vdx3" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (HCC)</span></p><p>Malignant neoplasm of prostate</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id13" href="#toc">Admitting Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="adx63" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (HCC)</span></p><p>Malignant neoplasm of prostate</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id14" href="#toc">Administered Medications</a></h3><div><table ID="admMedTable73"><span style="font-weight:bold; ">Inactive Administered Medications - up to 3 most recent administrations</span><colgroup><col width="40%"/><col span="5" width="12%"/></colgroup><thead><tr><th>Medication Order</th><th>MAR Action</th><th>Action Date</th><th>Dose</th><th>Rate</th><th>Site</th></tr></thead><tbody><tr class="xRowNormal xmedRow"><td class="Rrule"><p>fentaNYL (SUBLIMAZE) injection 25 mcg</p><p>25 mcg, intravenous, every 5 min PRN, other, Option 1 for pain score 4-10, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, 6 doses, PACU, Option 1 Medication: Monitor and record pain scores and respiratory status. If both oral and IV options are ordered for same pain level, administer IV if patient not able to take oral medications., Indications: acute pain</p></td><td colspan="5"/></tr><tr class="xRowNormal xMergeUp"><td class="Rrule"/><td colspan="5"/></tr><tr class="xRowAlt xmedRow"><td class="Rrule" rowspan="1"><p>lactated ringer's infusion</p><p>50 mL/hr, intravenous, once, [REDACTED][REDACTED] at 0600, 1 dose, Pre-op</p></td><td>New Bag</td><td>[REDACTED]  5:59 AM CDT</td><td>50 mL/hr</td><td>50 mL/hr</td><td/></tr><tr class="xRowAlt xMergeUp"><td class="Rrule"/><td colspan="5"/></tr><tr class="xRowNormal xmedRow"><td class="Rrule" rowspan="1"><p>lidocaine (XYLOCAINE) 10 mg/mL (1 %) injection</p><p>PRN, Starting [REDACTED][REDACTED] at 0755, Until [REDACTED] at 1003, Intra-op</p></td><td>Given</td><td>[REDACTED]  7:55 AM CDT</td><td>6 mL</td><td> </td><td>Surgical Site</td></tr><tr class="xRowNormal xMergeUp"><td class="Rrule"/><td colspan="5"/></tr><tr class="xRowAlt xmedRow"><td class="Rrule"><p>naloxone (NARCAN) 0.4 mg/mL injection 0.1 mg</p><p>0.1 mg, intravenous, every 1 min PRN, respiratory depression, as needed for respiratory rate 8 per minute or less OR patient somnolent and difficult to arouse (POSS GREATER than 3)., Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Repeat Naloxone 0.1 mg once in 2 minutes if necessary (MAXIMUM 0.2 mg).  If naloxone is needed, please call the ordering physician and/or CERT team.  Monitor vital signs (pulse oximetry, P/R/BP) every 15 minutes for 3 times.  Notify Anesthesia if administered.</p></td><td colspan="5"/></tr><tr class="xRowAlt xMergeUp"><td class="Rrule"/><td colspan="5"/></tr><tr class="xRowNormal xmedRow"><td class="Rrule"><p>ondansetron (ZOFRAN) injection 4 mg</p><p>4 mg, intravenous, once PRN, nausea, vomiting, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Give if patient is UNable to tolerate oral medication OR if a faster onset of action is required. May cause QTc prolongation.</p></td><td colspan="5"/></tr><tr class="xRowNormal xMergeUp"><td class="Rrule"/><td colspan="5"/></tr><tr class="xRowAlt xmedRow"><td class="Rrule"><p>ondansetron ODT (ZOFRAN-ODT) disintegrating tablet 4 mg</p><p>4 mg, oral, once PRN, nausea, vomiting, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Give if patient is able to tolerate oral medication. May cause QTc prolongation.</p></td><td colspan="5"/></tr><tr class="xRowAlt xMergeUp"><td class="Rrule"/><td colspan="5"/></tr><tr class="xRowNormal xmedRow"><td class="Rrule" rowspan="1"><p>sodium chloride 0.9% flush</p><p>PRN, Starting [REDACTED][REDACTED] at 0755, Until [REDACTED] at 1003, Intra-op</p></td><td>Given</td><td>[REDACTED]  7:55 AM CDT</td><td>5 mL</td><td> </td><td>Surgical Site</td></tr><tr class="xRowNormal xMergeUp"><td class="Rrule"/><td colspan="5"/></tr></tbody></table>documented in this encounter</div><h3><a name="id15" href="#toc">Active and Recently Administered Medications</a></h3><div><span class="xAlert">Times are shown in CDT.</span><table ID="MARTable91"><span style="font-weight:bold; ">Scheduled</span><colgroup><col width="40%"/><col span="3" width="20%"/></colgroup><thead><tr><th>Medication Order</th><th>[REDACTED]</th><th>[REDACTED]</th><th>[REDACTED]</th></tr></thead><tbody><tr ID="med88"><td><p><span class="content_span">ceFAZolin 2 g in sodium chloride 0.9 % MBP 50 mL IVPB (COMPLETED)</span><br/><span class="xIndent">2 g, intravenous, at 100 mL/hr, Administer over 30 Minutes, once, [REDACTED][REDACTED] at 0600, 1 dose, Pre-op, Reason for Therapy: Surgical Prophylaxis</span></p><br/></td><td><br/></td><td><br/></td><td><ul><li><span class="content_span">0742 (New Bag - Provider: [REDACTED], CRNA)</span></li></ul><br/></td></tr><tr ID="med89"><td class="Toprule"><p><span class="content_span">lactated ringer's infusion (COMPLETED)</span><br/><span class="xIndent">50 mL/hr, intravenous, once, [REDACTED][REDACTED] at 0600, 1 dose, Pre-op</span></p><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td><td class="Toprule"><ul><li><span class="content_span">0559 (New Bag - Provider: [REDACTED], RN)</span></li></ul><br/></td></tr></tbody></table><table ID="MARTable92"><span style="font-weight:bold; ">PRN</span><colgroup><col width="40%"/><col span="3" width="20%"/></colgroup><thead><tr><th>Medication Order</th><th>[REDACTED]</th><th>[REDACTED]</th><th>[REDACTED]</th></tr></thead><tbody><tr ID="med83"><td><p><span class="content_span">fentaNYL (SUBLIMAZE) injection 25 mcg</span><br/><span class="xIndent">25 mcg, intravenous, every 5 min PRN, other, Option 1 for pain score 4-10, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, 6 doses, PACU, Option 1 Medication: Monitor and record pain scores and respiratory status. If both oral and IV options are ordered for same pain level, administer IV if patient not able to take oral medications., Indications: acute pain</span></p><br/></td><td><br/></td><td><br/></td><td><br/></td></tr><tr ID="med76"><td class="Toprule"><p><span class="content_span">lidocaine (XYLOCAINE) 10 mg/mL (1 %) injection</span><br/><span class="xIndent">PRN, Starting [REDACTED][REDACTED] at 0755, Until [REDACTED] at 1003, Intra-op</span></p><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td><td class="Toprule"><ul><li><span class="content_span">0755 (Given - Provider: [REDACTED], MD)</span></li></ul><br/></td></tr><tr ID="med87"><td class="Toprule"><p><span class="content_span">naloxone (NARCAN) 0.4 mg/mL injection 0.1 mg</span><br/><span class="xIndent">0.1 mg, intravenous, every 1 min PRN, respiratory depression, as needed for respiratory rate 8 per minute or less OR patient somnolent and difficult to arouse (POSS GREATER than 3)., Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Repeat Naloxone 0.1 mg once in 2 minutes if necessary (MAXIMUM 0.2 mg).  If naloxone is needed, please call the ordering physician and/or CERT team.  Monitor vital signs (pulse oximetry, P/R/BP) every 15 minutes for 3 times.  Notify Anesthesia if administered.</span></p><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td></tr><tr ID="med85"><td class="Toprule"><p><span class="content_span">ondansetron (ZOFRAN) injection 4 mg</span>(Linked Group 1)<br/><span class="xIndent">4 mg, intravenous, once PRN, nausea, vomiting, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Give if patient is UNable to tolerate oral medication OR if a faster onset of action is required. May cause QTc prolongation.</span></p><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td></tr><tr ID="med86"><td class="Toprule"><p><span class="content_span">ondansetron ODT (ZOFRAN-ODT) disintegrating tablet 4 mg</span>(Linked Group 1)<br/><span class="xIndent">4 mg, oral, once PRN, nausea, vomiting, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Give if patient is able to tolerate oral medication. May cause QTc prolongation.</span></p><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td></tr><tr ID="med75"><td class="Toprule"><p><span class="content_span">sodium chloride 0.9% flush</span><br/><span class="xIndent">PRN, Starting [REDACTED][REDACTED] at 0755, Until [REDACTED] at 1003, Intra-op</span></p><br/></td><td class="Toprule"><br/></td><td class="Toprule"><br/></td><td class="Toprule"><ul><li><span class="content_span">0755 (Given - Provider: [REDACTED], MD)</span></li></ul><br/></td></tr></tbody></table><table ID="MARTable93"><span style="font-weight:bold; ">Linked Groups</span><colgroup><col width="100%"/></colgroup><thead><tr><th>Order</th></tr></thead><tbody><tr ID="lnk90"><td><p>Group 1:</p><p><span class="content_span">ondansetron ODT (ZOFRAN-ODT) disintegrating tablet 4 mg</span>Jump to med<br/><span class="xIndent">4 mg, oral, once PRN, nausea, vomiting, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Give if patient is able to tolerate oral medication. May cause QTc prolongation.</span></p><br/></td></tr><tr><td><p>Or</p><p><span class="content_span">ondansetron (ZOFRAN) injection 4 mg</span>Jump to med<br/><span class="xIndent">4 mg, intravenous, once PRN, nausea, vomiting, Starting [REDACTED][REDACTED] at 0649, Until [REDACTED] at 1050, PACU, Give if patient is UNable to tolerate oral medication OR if a faster onset of action is required. May cause QTc prolongation.</span></p><br/></td></tr></tbody></table>documented in this encounter</div><h3><a name="id16" href="#toc">Care Teams</a></h3><div><table ID="ct96"><colgroup><col span="3" width="25%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Family Medicine</td><td>[REDACTED]</td><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>